Vitura Health’s profits have doubled, leading to a second dividend for shareholders. However, the company’s shares have dropped by 10%. Leave a comment
Despite announcing a year-end after-tax profit of A$13.8 million, over twice the amount from the previous year, Vitura Health experienced a 10% decrease in its share price yesterday. The company’s revenue also saw a substantial increase of 75%, reaching $117.3 million. This growth was largely attributed to the sales of Medicinal Cannabis products, which accounted for $115 million, marking a 65% increase from FY22.
About the Author
Our deep love of plants and fascination with Cannabis has enabled over 25 years of successful small-scale Marijuana cultivation from indoor hydroponics, greenhouses, and outdoor growing set-ups.
As Cannabis laws around the world change, *we support the movement toward freedom of choice for responsible, consenting adults who wish to experience the joy and wonder of growing a Cannabis plant.
